The role of interleukin 35 in atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|35|5151-5159

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.35, 2015-10, pp. : 5151-5159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Lysophosphatidylcholine (LPC) in Atherosclerosis

By  

Current Medicinal Chemistry, Vol. 14, Iss. 30, 2007-12 ,pp. : 3209-3220

Bentham Science Publishers

Access to resources Recommend Favorite

Pathophysiology of Atherosclerosis: The Role of Inflammation

By  

Current Pharmaceutical Design, Vol. 17, Iss. 37, 2011-12 ,pp. : 4089-4110

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Micronutrients on Subclinical Atherosclerosis Micronutrients in Subclinical Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 22, Iss. 2, 2016-01 ,pp. : 221-229

Bentham Science Publishers

Access to resources Recommend Favorite

IL-35: a potential target for the treatment of atherosclerosis

By Huang Ying   Lin Ying-Zhong   Shi Ying   Ji Qing-Wei  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 10, 2013-10 ,pp. : 793-795

Govi-Verlag

Access to resources Recommend Favorite

The potential role of IL-37 in atherosclerosis

By Wu Bang-Wei   Zeng Qiu-Tang   Meng Kai   Ji Qing-Wei  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 11, 2013-11 ,pp. : 857-860

Govi-Verlag

Access to resources Recommend Favorite